Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Nov 06, 2020

Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.

Nov 02, 2020

Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris

Oct 30, 2020

Mylan Statement Regarding Third Quarter 2020 Financial Results

Oct 30, 2020

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

Sep 15, 2020

Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mL

Sep 15, 2020

Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn

Sep 09, 2020

Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

Sep 09, 2020

Mylan to Present at the BofA Securities Virtual Global Healthcare Conference

Sep 08, 2020

Mylan to Acquire Aspen's Thrombosis Business in Europe

Sep 03, 2020

UPDATED – Mylan Statement Regarding Unit 7 Warning Letter

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2023 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.